CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Option exercise VP, CFO AND SECRETARY acquired 18,750 shares (option exercise)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 2,655 shares (grant or award)
- 4 Grant or award VP, CFO AND SECRETARY acquired 3,575 shares (grant or award)
- 4 Grant or award PRES./CHIEF SCIENTIFIC OFFICER acquired 3,623 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 3,623 shares (grant or award)
- CT ORDER Other Confidential Order
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 4 Open-market sale VP, CFO AND SECRETARY sold 30,000 shares at $3.13 ($93,750)
- 4 Gift PRES./CHIEF SCIENTIFIC OFFICER gave 740 shares (gift)
- 4 Open-market buy PRES./CHIEF SCIENTIFIC OFFICER bought 3,750 shares at $2.73 ($10,238)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
Page 16 of 46 · 909 filings